1. Nordgaard I, Hansen BS, Mortensen PB: Importance of colonic support for energy absorption as small-bowel failure proceeds. Am J Clin Nutr64:222–231, 1996
2.
2. Nordgaard I, Hansen BS, Mortensen PB: Colon as a digestive organ in patients with short bowel. Lancet33:373–376, 1994
3.
3. Woolf GM, Miller C, Kurian R, et al: Diet for patients with a short bowel: High fat or high carbohydrate?Gastroenterology84:823–828, 1983
4.
4. McIntyre PB, Fitchew M, Lennard-Jones JE: Patients with a high jejunostomy do not need a special diet. Gastroenterology91:25–33, 1986
5.
5. Jeppesen PB, Mortensen PB: The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut43:478–483, 1998
6.
6. Marteau P, Messing B, Arrigoni E, et al: Do patients with short-bowel syndrome need a lactose-free diet?Nutrition13:13–16, 1997
7.
7. Behrend C, Jeppesen PB, Mortensen PB: Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: Effect of ileal resection and time span after surgery. Eur J Gastro Hepat7:397–400, 1995
8.
8. Dobbins JW, Binder HJ: Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology70:1096–1100, 1976
9.
9. Heydom S, Jeppesen PB, Mortensen PB: Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome. Scand J Gastro34:818–823, 1999
10.
10. Gruy-Kapral C, Little KH, Fordtran JS, et al: Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology116:15–21, 1999
11.
11. Lennard-Jones JE: Oral rehydration solutions in short bowel syndrome. Clin Ther12(suppl A):129–137, 1990
12.
12. Beaugerie L, Carbonnel F, Hecketsweiler B, et al: Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with a short-bowel. Aliment Pharmacol Ther11:741–746, 1997
13.
13. Newton CR, Gonvers JJ, McIntyre PB, et al: Effect of different drinks on fluid and electrolyte losses from a jejunostomy. J R Soc Med78:27–34, 1985
14.
14. Rodriguez-Iturbe B, Herrera J, Garcia R: Relationship between glomerular filtration rate and renal blood flow at different levels of protein-induced hyperfiltration in man. Clin Sci (Lond)74:11–15, 1988
15.
15. Crow M, Meyer GW: “Cholera solution” in short bowel syndrome. South Med J71:1303, 1978
16.
16. Griffin GE, Fagan EF, Hodgson HJ: Enteral therapy in the management of massive gut resection complicated by chronic fluid and electrolyte depletion. Dig Dis Sci27:902–908, 1982
17.
17. Laustsen J, Fallingborg J: Enteral glucose-polymer-electrolyte solution in the treatment of chronic fluid and electrolyte depletion in short-bowel syndrome. Acta Chir Scand149:787–788, 1983
18.
18. MacMahon RA: The use of the World Health Organization's oral rehydration solution in patients on home parenteral nutrition. JPEN8:720–721, 1984
19.
19. Ward K, Murray B, Neale G: Treatment of salt losing ileostomy diarrhoea with an oral glucose polymer electrolyte solution. Ir J Med Sci153:77–78, 1984
20.
20. Camllleri M, Prather CM, Evans MA, et al: Balance studies and polymeric glucose solution to optimize therapy after massive intestinal resection. Mayo Clinic Proc67:755–760, 1992
21.
21. Beaugerie L, Cosnes J, Verwaerde F, et al: Isotonic high-sodium oral rehydration solution for increasing sodium absorption in patients with short-bowel syndrome. Am J Clin Nutr53:769–772, 1991
22.
22. Ladefoged K, Christensen KC, Hegnhoj J, et al: Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut30:943–949, 1989
23.
23. O'Keefe SJ, Peterson ME, Fleming CR: Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN18:26–34, 1994
24.
24. O'Keefe SJ, Haymond MW, Bennet WM, et al: Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology107:379–388, 1994
25.
25. Nehra V, Camllleri M, Burton D, et al: An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol2001;96:1494–1498
26.
26. Ellegard L, Bosaeus I, Nordgren S, et al: Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg225:88–96, 1997
27.
27. Scolapio JS, McGreevy K, Tennyson GS, et al: Effect of glutamine in short-bowel syndrome. Clin Nutr20:319–323, 2001
28.
28. Scolapio JS, Camllleri M, Fleming CR, et al: Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: A randomized, controlled study. Gastroenterology113:1074–1081, 1997
29.
29. Scolapio JS: Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: A randomized, controlled study. JPEN23:309–313, 1999
30.
30. Szkudlarek J, Jeppesen PB, Mortensen PB: Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: A randomised, double-blind, crossover, placebo-controlled study. Gut47:199–205, 2000
31.
31. Byrne TA, Morrissey TB, Nattakom TV et al, Growth hormone glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN19:296–302, 1995
32.
32. Byrne TA, Persinger RL, Young LS, et al: A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg222:243–255, 1995
33.
33. Jeppesen PB, Hartmann B, Thulesen J, et al: Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology120:806–815, 2001
